🎗️ Turkey Tail has been approved as a cancer therapy in Japan for 50 years. The West is only now catching up.
Trametes versicolor. The most studied medicinal mushroom on Earth.
PSK (polysaccharide-K) is a protein-bound beta-glucan extracted from turkey tail. In Japan it’s been an approved cancer adjunct therapy since 1977 under the brand name Krestin. Millions of Japanese cancer patients receive it alongside chemotherapy annually.
The clinical data is not subtle:
In a randomised trial of 918 gastric cancer patients (Stage II and III), PSK measurably improved antitumour immune function — with significantly better long-term survival outcomes, particularly in PD-L1 negative patients.
A Phase I Bastyr/University of Washington trial (FDA approved, NIH funded) showed daily turkey tail after radiotherapy increased natural killer cell activity and lymphocyte counts in breast cancer patients.
The mechanism: PSK binds immune receptors on dendritic cells, activating the innate immune response and training the immune system to attack cancer cells more aggressively.
This isn’t fringe. It’s 50 years of Japanese clinical practice.
The mushroom growing on the log outside your window is being administered in Tokyo oncology wards right now.
Why has the West been so slow to run these trials? Money, evidence, or something else? 🎗️
#MycelNet #TurkeyTail #Fungi #Mushroom
